Compare iShares Core MSCI Emerging Markets ETF (IEMG) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI Emerging Markets ETF vs Altria Group Inc — how do they compare? iShares Core MSCI Emerging Markets ETF trades at $81.28 (market cap $162.00B), while Altria Group Inc trades at $71.5 (market cap $119.25B). The key difference: iShares Core MSCI Emerging Markets ETF is the larger of the two by market cap, and Altria Group Inc pays a 6.22% dividend while iShares Core MSCI Emerging Markets ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI Emerging Markets ETF for 57 Days and Altria Group Inc for 154 Days on average.
| IEMG | MO | |
|---|---|---|
Market Cap | $162.00B | $119.25B |
Volume | 13,446,151 | 11,178,169 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $86.00 | $74.92 |
52-Week Low | $64.22 | $54.72 |
Typical Hold Time | 57 Days | 154 Days |
Enterprise Value | — | $141.46B |
Dividend Yield | — | 6.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEMG trades at $82.04, down 1.2% on the day, with a bullish technical signal driven by moving averages. The emerging markets ETF has demonstrated strong performance with 35% returns over the past year, though it faces higher volatility than broader international alternatives. Recent news highlights IEMG's significant technology sector exposure (39%) and competitive positioning against peers like SCHE and VWO.
The outlook remains positive given emerging markets momentum and record capital inflows, though investors face currency risk and concentration concerns. IEMG's 0.09% expense ratio provides cost efficiency for emerging markets exposure, but the fund's heavier tech weighting and historical drawdowns require careful risk management in volatile market conditions.
Altria Group (MO) trades at $69.39, up 1.22% today, near the analyst consensus price target of $69.71. The stock shows a bullish technical trend with strong moving average signals, while oscillators remain neutral. Fundamentally, the company maintains robust profitability with a 39% net income margin and strong cash flow, though revenue has been slightly declining. Recent earnings have been mixed, with one beat and two misses in the last three quarters. A high dividend yield of approximately 6.6% is supported by 60 consecutive annual increases, but the balance sheet shows negative shareholder equity.
The outlook for MO balances income appeal against structural challenges. The high dividend and bullish analyst consensus (61.5% buy ratings) offer value for income investors, but risks include declining core tobacco sales, regulatory pressures on nicotine products, and a leveraged balance sheet. Earnings growth and smoke-free product adoption are critical for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
